Johnson & Johnson: Velys knee surgery robot
(Image courtesy of Johnson & Johnson)
J&J’s DePuy Synthes expects to launch its Velys table-mounted knee robot this year, following FDA clearance in January.
DePuy Synthes touts the Velys robotic-assisted platform as a first-of-its-kind, table-mounted solution with an efficient design capable of integrating into any operating room. The company said it adapts to a surgeon’s workflow, offers control they are used to, and helps execute accurate bony cuts.
Velys also system offers gap balance data for visualization and joint stability predictions, along with accurate, consistent plan execution supporting the Attune total knee system, according to J&J, which acquired the Velys system from its developer Orthotaxy in 2018.
J&J also plans to launch several other devices this year, including:
- Its Veritas cataract surgery system globally this year. The next-generation phacoemulsification system secured FDA 510k clearance and CE mark in February. Phacoemulsification is the most common cataract surgery technique performed and allows ophthalmologists to effectively emulsify and efficiently remove the eye’s internal lens when it has become cloudy from cataracts. It is a delicate procedure that requires significant effort and control during surgery, which can be taxing on the surgeon, according to J&J.
- A dual mobility system addition to DePuy Synthes’ Pinnacle acetabular cup system. The Pinnacle dual mobility system is a modular system that combines the Pinnacle acetabular cup system and the Bi-Mentum dual mobility polyethylene liner to provide enhanced stability hip construct.
- A 2.7 mm variable-angle locking compression plate clavicle plate system for the treatment of lateral, shaft and medial fractures for small, medium and large stature patients, also from DePuy Synthes. The new system offers plate shapes that reflect the correlation between patient stature and clavicle size to match the bow and contour of the clavicle and accommodates the anatomic variability of the clavicle, according to the company.
- The Acclarent Pivot balloon dilation system, which gained FDA clearance in August 2020. The device, made by J&J company Acclarent, has a dual indication for balloon sinuplasty and Eustachian tube balloon dilation and can be used in conjunction with the company’s TruDi ENT navigation system to allow for navigated procedures.
